LobbyingRoman Health Ventures lobbying by quarter
Roman Health Ventures's latest lobbying report covers Q2 2026, at $120K. Its first report covers Q1 2026; the issues it reports most are Health Issues and Consumer Issues/Safety/Protection.
Roman Health Ventures
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $280K
- Last 3 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $160K | 1 |
| Q2 2026 | $120K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$200K · 2 reports
- Consumer protection and safety$40K · 1 reports
- Science and technology$40K · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES1 reports
- SENATE1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseRoman Health Ventures | $280K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $120K |
| 04/20for Q1 | In-house | $160K |
| 03/03for Q1 | In-house | Under $5,000 |